Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_assertion type Assertion NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_head.
- NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_assertion wasGeneratedBy ECO_0000203 NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_provenance.
- NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_assertion wasDerivedFrom befree-20140225 NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_provenance.
- NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_assertion SIO_000772 16505158 NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_provenance.
- NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_assertion evidence source_evidence_literature NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_provenance.
- NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_assertion description "[Clinically, CORDX3 shares some features with CSNB2 but is distinguishable from CSNB2 in that it is progressive, can begin in adulthood, has no nystagmus or hyperopic refraction, has only low grade astigmatism, and in dark adaptation lacks cone threshold and has small or no elevation of rod threshold.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792930.RAFnJnmkviOMGECMRNvFID9lygW4_OzrTQnOp5MVQNPHc130_provenance.